PGAM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.862100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.274400E-01
Normal-vs-Stage2
4.304300E-03
Normal-vs-Stage3
6.523200E-01
Normal-vs-Stage4
7.589600E-01
Stage1-vs-Stage2
7.081200E-01
Stage1-vs-Stage3
9.836200E-01
Stage1-vs-Stage4
8.174400E-01
Stage2-vs-Stage3
7.879800E-01
Stage2-vs-Stage4
5.143400E-01
Stage3-vs-Stage4
8.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.043700E-03
Normal-vs-AfricanAmerican
6.210400E-01
Normal-vs-Asian
2.354400E-01
Caucasian-vs-AfricanAmerican
5.344400E-01
Caucasian-vs-Asian
8.990800E-01
AfricanAmerican-vs-Asian
4.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.979900E-03
Normal-vs-Female
2.892400E-01
Male-vs-Female
3.895200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.886800E-01
Normal-vs-Age(41-60Yrs)
4.596500E-02
Normal-vs-Age(61-80Yrs)
3.124500E-02
Normal-vs-Age(81-100Yrs)
4.284000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.218000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.140400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.817000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.011100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.245700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.297200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.381400E-01
Normal-vs-Daily Drinker
5.492400E-02
Normal-vs-Weekly Drinker
9.274000E-02
Normal-vs-Occasional Drinker
2.955600E-03
Normal-vs-Social Drinker
2.933000E-01
Non Drinker-vs-Daily Drinker
1.936230E-01
Non Drinker-vs-Weekly Drinker
1.838810E-01
Non Drinker-vs-Occasional Drinker
1.020310E-02
Non Drinker-vs-Social Drinker
1.019770E-01
Daily Drinker-vs-Weekly Drinker
8.222000E-01
Daily Drinker-vs-Occasional Drinker
1.741420E-01
Daily Drinker-vs-Social Drinker
6.457800E-01
Weekly Drinker-vs-Occasional Drinker
3.384400E-01
Weekly Drinker-vs-Social Drinker
8.498400E-01
Occasional Drinker-vs-Social Drinker
4.072200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.682200E-01
Normal-vs-Grade 2
7.870200E-01
Normal-vs-Grade 3
7.859600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.036900E-03
Grade 1-vs-Grade 3
1.542210E-02
Grade 1-vs-Grade 4
9.682200E-01
Grade 2-vs-Grade 3
9.760000E-01
Grade 2-vs-Grade 4
7.870200E-01
Grade 3-vs-Grade 4
7.859600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.478100E-02
Normal-vs-NonDiabetic
3.391800E-01
Diabetic-vs-NonDiabetic
9.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.308400E-02
Normal-vs-NoPancreatitis
5.177300E-03
Pancreatitis-vs-NoPancreatitis
1.515630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.371690E-02
Normal-vs-N1
2.899700E-03
N0-vs-N1
6.409200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.625200E-01
Normal-vs-TP53-NonMutant
8.276400E-01
TP53-Mutant-vs-TP53-NonMutant
1.030930E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
